Historically, cannabis companies operating in the United States have been locked out of one of the most fundamental tools available to American businesses: the ability to list on a major U.S. stock exchange. On June 5, 2026, that changed.
Trulieve Cannabis Corp. announced that its shares have been approved for listing on the New York Stock Exchange, with trading set to begin under the ticker “TRLV” on June 10. The Tallahassee-based company bills itself as a leading medical cannabis operator in the U.S. But the headline isn’t the company—it’s the moment. This is a first, and in an industry that has been waiting years for mainstream legitimacy, firsts matter.
